Healthcare -
Biotechnology - NASDAQ - US
$ 3.345
1.36 %
$ 634 M
Market Cap
-7.78
P/E
ABUS - TOTAL RECEIVABLES
Total Receivables ABUS - Arbutus Biopharma Corporation
1.78 M
LAST VALUE
40.55%
2 YEAR CAGR
4.41%
5 YEAR CAGR
18.37%
10 YEAR CAGR